Escitalopram and Duloxetine in Major Depressive Disorder: A Pharmacoeconomic Comparison Using UK Cost Data

By Wade Alan G.  

PharmacoEconomics, Vol. 26, Iss. 11, 2008-01 ,pp. : 969-981

Adis International

Access to resources Recommend Favorite

Consider augmentation or switching strategies when first-line antidepressants are unsuccessful in major depressive disorder

By  

Drugs & Therapy Perspectives, Vol. 27, Iss. 12, 2011-12 ,pp. : 7-12

Adis International

Access to resources Recommend Favorite

Vilazodone: In Major Depressive Disorder

By Frampton James E.  

CNS Drugs, Vol. 25, Iss. 7, 2011-07 ,pp. : 615-627

Adis International

Access to resources Recommend Favorite

Aripiprazole: In Major Depressive Disorder

By Weber Juliane   Lyseng-Williamson Katherine A.   Scott Lesley J.  

CNS Drugs, Vol. 22, Iss. 10, 2008-01 ,pp. : 807-813

Adis International

Access to resources Recommend Favorite

Quetiapine XR efficacy and tolerability as monotherapy and as adjunctive treatment to conventional antidepressants in the acute and maintenance treatment of major depressive disorder: a review of registration trials

By McIntyre Roger S   Muzina David J   Adams Amanda   Lourenco Maria Teresa C   Law Candy WY   Soczynska Joanna K   Woldeyohannes Hanna O   Nathanson Jay   Kennedy Sidney H  

Expert Opinion on Pharmacotherapy, Vol. 10, Iss. 18, 2009-12 ,pp. : 3061-3075

Informa Healthcare

Access to resources Recommend Favorite